Cart
sales@molnova.com
Gipsoside
CAS No. 15588-68-8
Gipsoside( —— )
Catalog No. M20402 CAS No. 15588-68-8
Gipsoside is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 157 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGipsoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionGipsoside is a natural product.
-
DescriptionGipsoside is a natural product.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15588-68-8
-
Formula Weight1791.8
-
Molecular FormulaC80H126O44?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](OC4O[C@@H]([C@@H](OC5O[C@H](CO)[C@@H](OC6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](OC5OC[C@H](O)[C@H](O)[C@H]5O)[C@H]4O)C(O)=O)[C@@](C)(C=O)[C@]3([H])CC[C@@]12C)C(=O)OC1O[C@@H](C)[C@H](OC2O[C@H](C)[C@H](O)[C@H](OC3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O)[C@@H](O)[C@H]1OC1OC[C@@H](O)[C@H](OC2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Iatsyno A I . [Effect of gypsozide on the course of experimental cholesterol atherosclerosis in rabbits].[J]. Farmakologiia I Toksikologiia 1969 32(6):687-689.
molnova catalog
related products
-
Naringin 6-acetate
The peels of Citrus maxima.
-
2-Hydroxystearic aci...
2-Hydroxystearic acid is a hydroxy fatty acid found in humans and U. armoricana. It reduces the growth of Ehrlich ascites tumor (EAT) cells in vitro when used at a concentration of 100 μM.
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
